Medical Oncologist
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Lombardia, Italy
A medical oncologist, Silvia Stacchiotti has a life-time professional dedication to patient care and research in bone and soft tissue sarcoma (STS), and gastrointestinal stromal tumor (GIST).
She works in the Adult Mesenchymal and Rare Tumor Medical Treatment Unit, Cancer Medicine Department. at the Fondazione IRCCS Istituto Nazionale Tumori (Milan, Italy) where she is involved in all institutional research activities on sarcoma, with a special focus on ultra-rare sarcomas.
She is the current president of the Italian Sarcoma Group (ISG), the Italian scientific society for research and care of all ages sarcoma patients, and the current treasurer of the Connective Tissue Oncology Society (CTOS). She is the secretary of the EORTC Soft Tissue and Bone Sarcoma Group. She is the faculty coordinator of the Sarcoma group of the European Society for Medical Oncology (ESMO) and the subject editor of the ESMO guidelines committee for sarcoma and GIST. She is member of the advisory boards of Alleanza Contro il Cancro (ACC) and of the Federazione Italiana Gruppi Cooperativi (FICOG). She collaborates with several sarcoma Patient Advocacy Groups (PAG), among which the Chordoma Foundation, the Epithelioid Haemangioendothelioma (EHE) Rare Cancer Charity UK (EHERCC) the EHE Foundation US, the Desmoid Tumor Research Foundation, the Leiomyosarcoma Foundation, in which she serves as a member of the corresponding medical advisory boards. She is the Principal Investigator of several trials on sarcoma. She has authored >230 scientific publications (H Index 59).
Born in 1968, Silvia Stacchiotti received her medical degree in 1993, in Milan, and trained at INT. She is certified in Clinical Oncology. She has four children.
Opening Session and Celebration of CTOS 30
Thursday, November 13, 2025
8:00 AM - 9:30 AM EST
Disclosure information not submitted.
Thursday, November 13, 2025
6:30 PM - 7:45 PM EST
Disclosure information not submitted.
Friday, November 14, 2025
8:30 AM - 10:00 AM EST
Disclosure information not submitted.
Paper 32 - RADIOLOGIC RESPONSES IN EPITHELIOID HEMANGIOENDOTHELIOMA: BEYOND RECIST?
Friday, November 14, 2025
10:30 AM - 12:00 PM EST
Disclosure information not submitted.
Paper 35 - A POOLED ANALYSIS OF PHASE 2 CLINICAL TRIALS IN ADVANCED CHORDOMA
Friday, November 14, 2025
10:30 AM - 12:00 PM EST
Disclosure information not submitted.
Friday, November 14, 2025
10:30 AM - 12:00 PM EST
Disclosure information not submitted.
Friday, November 14, 2025
1:30 PM - 2:30 PM EST
Disclosure information not submitted.
Friday, November 14, 2025
1:30 PM - 2:30 PM EST
Disclosure information not submitted.
Friday, November 14, 2025
2:30 PM - 3:30 PM EST
Disclosure information not submitted.
Friday, November 14, 2025
2:30 PM - 3:30 PM EST
Disclosure information not submitted.
Friday, November 14, 2025
5:00 PM - 6:00 PM EST
Disclosure information not submitted.
Saturday, November 15, 2025
9:00 AM - 10:30 AM EST
Disclosure information not submitted.
Saturday, November 15, 2025
4:00 PM - 5:00 PM EST
Disclosure information not submitted.